CSD500 - The Market
The condom market
In 2012, the global retail condom market was estimated to be worth US$3.5 billion.
Futura commissioned a pricing and demand research study by Millward Brown, an internationally respected agency. This research, carried out in the UK and USA, confirmed Futura's confidence in CSD500 as a highly innovative disruptive technology which has the potential to fundamentally change the condom market. The research has been shared with potential licensing partners but the key highlights are:
- CSD500 will command a price premium over existing condoms
- CSD500 is expected to gain a market share in excess of 10% in the markets researched
- CSD500 is expected to grow the condom category because of its appealing proposition and unique claims
Impact of loss of sensitivity on condom use and sexual health
Previous research has also shown that up to 46% of men have experienced some loss of sensitivity when using a condom during sexual intercourse, which can lead to loss of erection on occasions. This is one reason why some men avoid condoms for either part of or for the duration of sexual intercourse, thereby increasing the risks of unwanted pregnancies and contracting sexually transmitted infections ("STIs").
The consequences of unprotected sex are further supported by the UK government's Health Protection Agency's report published in May 2012, which showed that the number of new cases of STIs in the UK continues to rise, with an increase of 42% over the past ten years.
CSD500 has been approved by European regulators as a condom to be used by healthy men to help maintain a firmer erection during intercourse whilst wearing a condom. CSD500 has been launched in Holland, Belgium and in Saudi Arabia with further launches of the product expected in other countries during 2017 and beyond.